Table 2 Matching baseline characteristics of the non-DM subjects from the three compared groups
From: Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes
PCSK9iG (n = 168) | PSMG (n = 168) | Di@bet.es study (n = 563) | |
|---|---|---|---|
Age (years) | 59.5 ± 10.6 | 65.4 ± 11.8 | 64.5 ± 10.5 |
Sex (male, %) | 52.4 | 50.8 | 39.7 |
BMI (kg/m2) | 28.6 ± 4.7 | 28 ± 4.5 | 27.5 ± 4.7 |
Fasting glucose (mg/dL) | 98.2 ± 12.4 | 95.6 ± 11.2 | 91.9 ± 12.6 |
A1c (%) | 5.7 ± 0.4 | 6.2 ± 6.3 (n = 96) | N/A |
FH (%) | 72.6 | 72.6 | N/A |